Anna Cantalupo

Dr. Anna Cantalupo

Icahn School of Medicine at Mount Sinai, New York, NY USA
orcid

Biography

Trained as vascular biologist and pharmacologist, I received my PhD in Pharmaceutical Sciences from the University of Naples Federico II in Italy. During my graduate training, I unveiled the mechanisms underlying the beneficial effects of Zofenopril, a sulphydrilated angiotensin converting enzyme (ACE) inhibitor on cardiovascular functions. During my first postdoctoral training in the lab of Annarita Di Lorenzo at Weill Cornell Medicine (2013-2017), I made two major discoveries that were published in very high-impact factor journals: the endoplasmic reticulum protein Nogo-B is a crucial regulator of sphingolipid biosynthesis and sphingosine 1-phosphate (S1P) within the vascular wall (Nature Med 2015); endothelial-derived S1P and its S1P receptor-1 (S1PR1) mediated signal on endothelial cells of blood vessels is of fundamental importance in blood flow and pressure regulation (Hypertension 2017). From January 2019 I joined the lab of Ramirez Francesco at Icahn School of Medicine at Mount Sinai where I am studying the role of endothelial dysfunction in the pathogenesis of thoracic aortic aneurysm and dissection in Marfan syndrome, a connective tissue disorder caused by mutation of the extracellular matrix protein, fibrillin-1. I currently hold a position as Instructor and earned Early Career Award from the Marfan Foundation.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.